These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9935167)
1. Interleukin-10 gene transfer activates interferon-gamma and the interferon-gamma-inducible genes Gbp-1/Mag-1 and Mig-1 in mammary tumors. Sun H; Jackson MJ; Kundu N; Fulton AM Int J Cancer; 1999 Feb; 80(4):624-9. PubMed ID: 9935167 [TBL] [Abstract][Full Text] [Related]
2. Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors. Sun H; Kundu N; Dorsey R; Jackson MJ; Fulton AM J Immunother; 2001; 24(2):138-43. PubMed ID: 11265771 [TBL] [Abstract][Full Text] [Related]
3. Essential role of nitric oxide and interferon-gamma for tumor immunotherapy with interleukin-10. Sun H; Gutierrez P; Jackson MJ; Kundu N; Fulton AM J Immunother; 2000; 23(2):208-14. PubMed ID: 10746547 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide. Kundu N; Dorsey R; Jackson MJ; Guiterrez P; Wilson K; Fu S; Ramanujam K; Thomas E; Fulton AM Int J Cancer; 1998 May; 76(5):713-9. PubMed ID: 9610731 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Dorsey R; Kundu N; Yang Q; Tannenbaum CS; Sun H; Hamilton TA; Fulton AM Cancer Res; 2002 May; 62(9):2606-10. PubMed ID: 11980656 [TBL] [Abstract][Full Text] [Related]
6. Expression of the Chemokines IP-10 and Mig in IL-10 Transduced Tumors. Sun H; Kundu N; Dorsey R; Jackson MJ; Fulton AM J Immunother (1991); 2001 Mar; 24(2):138-143. PubMed ID: 11449070 [TBL] [Abstract][Full Text] [Related]
7. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice. Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946 [TBL] [Abstract][Full Text] [Related]
8. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. Gasperini S; Marchi M; Calzetti F; Laudanna C; Vicentini L; Olsen H; Murphy M; Liao F; Farber J; Cassatella MA J Immunol; 1999 Apr; 162(8):4928-37. PubMed ID: 10202039 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 12-activated lymphocytes influence tumor genetic programs. Cavallo F; Quaglino E; Cifaldi L; Di Carlo E; André A; Bernabei P; Musiani P; Forni G; Calogero RA Cancer Res; 2001 Apr; 61(8):3518-23. PubMed ID: 11309316 [TBL] [Abstract][Full Text] [Related]
10. Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Lipnik K; Naschberger E; Gonin-Laurent N; Kodajova P; Petznek H; Rungaldier S; Astigiano S; Ferrini S; Stürzl M; Hohenadl C Mol Med; 2010; 16(5-6):177-87. PubMed ID: 20454519 [TBL] [Abstract][Full Text] [Related]
12. Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2). Park JW; Gruys ME; McCormick K; Lee JK; Subleski J; Wigginton JM; Fenton RG; Wang JM; Wiltrout RH J Immunol; 2001 Mar; 166(6):3763-70. PubMed ID: 11238618 [TBL] [Abstract][Full Text] [Related]
13. Transfection of the genes for interleukin-12 into the K1735 melanoma and the EMT6 mammary sarcoma murine cell lines reveals distinct mechanisms of antitumor activity. Moran JP; Gerber SA; Martin CA; Frelinger JG; Lord EM Int J Cancer; 2003 Sep; 106(5):690-8. PubMed ID: 12866028 [TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA. Oshikawa K; Shi F; Rakhmilevich AL; Sondel PM; Mahvi DM; Yang NS Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13351-6. PubMed ID: 10557324 [TBL] [Abstract][Full Text] [Related]
15. CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors. Gorbachev AV; Kobayashi H; Kudo D; Tannenbaum CS; Finke JH; Shu S; Farber JM; Fairchild RL J Immunol; 2007 Feb; 178(4):2278-86. PubMed ID: 17277133 [TBL] [Abstract][Full Text] [Related]
16. Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes. Musiani P; Modesti A; Brunetti M; Modica A; Vitullo P; Gulino A; Bosco MC; Colombo MP; Nanni P; Cavallo F Nat Immun; 1994; 13(2-3):93-101. PubMed ID: 8173240 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism. Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012 [TBL] [Abstract][Full Text] [Related]
18. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177 [TBL] [Abstract][Full Text] [Related]
19. Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model. Dias S; Thomas H; Balkwill F Int J Cancer; 1998 Jan; 75(1):151-7. PubMed ID: 9426704 [TBL] [Abstract][Full Text] [Related]
20. The murine chemokine CXCL11 (IFN-inducible T cell alpha chemoattractant) is an IFN-gamma- and lipopolysaccharide-inducible glucocorticoid-attenuated response gene expressed in lung and other tissues during endotoxemia. Widney DP; Xia YR; Lusis AJ; Smith JB J Immunol; 2000 Jun; 164(12):6322-31. PubMed ID: 10843686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]